Richard J. Whitley

43.7k total citations · 13 hit papers
404 papers, 26.9k citations indexed

About

Richard J. Whitley is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, Richard J. Whitley has authored 404 papers receiving a total of 26.9k indexed citations (citations by other indexed papers that have themselves been cited), including 350 papers in Epidemiology, 87 papers in Infectious Diseases and 51 papers in Genetics. Recurrent topics in Richard J. Whitley's work include Herpesvirus Infections and Treatments (276 papers), Cytomegalovirus and herpesvirus research (191 papers) and Virus-based gene therapy research (49 papers). Richard J. Whitley is often cited by papers focused on Herpesvirus Infections and Treatments (276 papers), Cytomegalovirus and herpesvirus research (191 papers) and Virus-based gene therapy research (49 papers). Richard J. Whitley collaborates with scholars based in United States, United Kingdom and Germany. Richard J. Whitley's co-authors include Bernard Roizman, David W. Kimberlin, Charles A. Alford, Fred D. Lakeman, John W. Gnann, Seng‐Jaw Soong, André J. Nahmias, Ann M. Arvin, W. Michael Scheld and Allan R. Tunkel and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Richard J. Whitley

394 papers receiving 25.3k citations

Hit Papers

Practice Guidelines for the Management... 1977 2026 1993 2009 2004 1998 2008 2007 1990 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Practice Guidelines for the Management of Bacterial Meningitis
    2004 1.4k citations Allan R. Tunkel, Barry J. Hartman et al. Clinical Infectious Diseases profile →
  2. Herpes Simplex Viruses
    1998 870 citations Richard J. Whitley, David W. Kimberlin et al. Clinical Infectious Diseases profile →
  3. The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America
    2008 702 citations Allan R. Tunkel, Carol Glaser et al. Clinical Infectious Diseases profile →
  4. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis
    2007 649 citations Ann M. Arvin, Gabriella Campadelli‐Fiume et al. profile →
  5. Mapping of Herpes Simplex Virus-1 Neurovirulence to γ 1 34.5, a Gene Nonessential for Growth in Culture
    1990 622 citations Richard J. Whitley, Bernard Roizman et al. profile →
  6. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial
    2003 615 citations David W. Kimberlin, Chin‐Yu Lin et al. profile →
  7. Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis
    1986 591 citations Richard J. Whitley, Charles A. Alford et al. profile →
  8. Oral oseltamivir treatment of influenza in children
    2001 541 citations Richard J. Whitley, Frederick G. Hayden et al. The Pediatric Infectious Disease Journal profile →
  9. Herpes Zoster
    2002 527 citations Richard J. Whitley et al. profile →
  10. Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex Encephalitis
    1977 498 citations Richard J. Whitley, Seng‐Jaw Soong et al. profile →
  11. Diagnosis of Herpes Simplex Encephalitis: Application of Polymerase Chain Reaction to Cerebrospinal Fluid from Brain-Biopsied Patients and Correlation with Disease
    1995 446 citations Fred D. Lakeman, Richard J. Whitley The Journal of Infectious Diseases profile →
  12. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
    2015 372 citations Richard J. Whitley et al. profile →
  13. Therapeutic strategies for COVID-19: progress and lessons learned
    2023 341 citations Richard J. Whitley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard J. Whitley United States 86 20.0k 7.4k 3.3k 3.0k 2.8k 404 26.9k
Stanley A. Plotkin United States 70 10.6k 0.5× 7.4k 1.0× 1.7k 0.5× 845 0.3× 3.6k 1.3× 461 20.2k
Herbert W. Virgin United States 98 16.0k 0.8× 10.4k 1.4× 4.7k 1.4× 6.0k 2.0× 12.7k 4.5× 258 38.7k
Ann M. Arvin United States 78 15.8k 0.8× 3.8k 0.5× 2.0k 0.6× 1.4k 0.5× 1.5k 0.5× 350 19.5k
Lawrence Corey United States 131 41.4k 2.1× 22.1k 3.0× 4.5k 1.3× 8.7k 2.9× 4.4k 1.6× 840 63.4k
Barry R. Bloom United States 93 13.4k 0.7× 13.9k 1.9× 2.1k 0.6× 2.1k 0.7× 7.0k 2.5× 333 33.8k
Anna Wald United States 76 17.4k 0.9× 7.5k 1.0× 1.0k 0.3× 2.8k 0.9× 839 0.3× 428 22.6k
André J. Nahmias United States 60 10.5k 0.5× 3.6k 0.5× 1.5k 0.5× 1.3k 0.4× 862 0.3× 246 14.4k
Akiko Iwasaki United States 91 8.8k 0.4× 7.4k 1.0× 1.6k 0.5× 2.6k 0.9× 10.0k 3.5× 264 36.8k
Michael B. A. Oldstone United States 107 10.7k 0.5× 9.7k 1.3× 5.9k 1.8× 3.0k 1.0× 7.7k 2.7× 536 39.7k
Ron A. M. Fouchier Netherlands 101 30.2k 1.5× 25.7k 3.5× 2.2k 0.7× 940 0.3× 6.5k 2.3× 462 48.0k

Countries citing papers authored by Richard J. Whitley

Since Specialization
Citations

This map shows the geographic impact of Richard J. Whitley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Whitley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Whitley more than expected).

Fields of papers citing papers by Richard J. Whitley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Whitley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Whitley. The network helps show where Richard J. Whitley may publish in the future.

Co-authorship network of co-authors of Richard J. Whitley

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Whitley. A scholar is included among the top collaborators of Richard J. Whitley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Whitley. Richard J. Whitley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Acosta, Edward P., Inmaculada Aban, Kevin J. Ryan, et al.. (2025). Ganciclovir Dosing in Premature Infants Receiving Treatment for Congenital Cytomegalovirus Infection: Results of a Prospective Pharmacokinetic Study. The Journal of Infectious Diseases.
2.
Kang, Kyung‐Don, Joshua D. Bernstock, Stacie K. Totsch, et al.. (2022). Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers. Clinical Cancer Research. 28(24). 5419–5430. 11 indexed citations
3.
Bernstock, Joshua D., Asim K. Bag, John B. Fiveash, et al.. (2020). Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors. Human Gene Therapy. 31(19-20). 1132–1139. 32 indexed citations
4.
Roth, Justin C., Kevin A. Cassady, James J. Cody, et al.. (2014). Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates. 776275620–776275620. 3 indexed citations
5.
6.
Kimberlin, David W., Mark J. Abzug, David J. Lang, et al.. (2010). Safety of Oseltamivir Compared With the Adamantanes in Children Less Than 12 Months of Age. The Pediatric Infectious Disease Journal. 29(3). 195–198. 32 indexed citations
7.
Tunkel, Allan R., Carol Glaser, Karen C. Bloch, et al.. (2008). The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases. 47(3). 303–327. 702 indexed citations breakdown →
8.
Campadelli‐Fiume, Gabriella, Edward S. Mocarski, Patrick S. Moore, et al.. (2007). KSHV gene expression and regulation -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 98(3). 652–4. 6 indexed citations
9.
Corey, Lawrence, et al.. (2007). An update on short-course intermittent and prevention therapies for herpes labialis.. PubMed. 14 Suppl 1. 13A–18A. 14 indexed citations
10.
Abzug, Mark J., Gretchen Cloud, John S. Bradley, et al.. (2003). Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. The Pediatric Infectious Disease Journal. 22(4). 335–340. 77 indexed citations
11.
Abzug, Mark J., Gretchen A. Cloud, John L. Bradley, et al.. (2003). . The Pediatric Infectious Disease Journal. 22(4). 335–340. 3 indexed citations
12.
Kimberlin, David W., Chin‐Yu Lin, Richard F. Jacobs, et al.. (2001). Natural History of Neonatal Herpes Simplex Virus Infections in the Acyclovir Era. PEDIATRICS. 108(2). 223–229. 310 indexed citations
13.
Whitley, Richard J., Frederick G. Hayden, Keith S. Reisinger, et al.. (2001). Oral oseltamivir treatment of influenza in children. The Pediatric Infectious Disease Journal. 20(2). 127–133. 541 indexed citations breakdown →
14.
Kimberlin, David W. & Richard J. Whitley. (1998). Human Herpesvirus-6: Neurologic Implications of a Newly-Described Viral Pathogen. Journal of NeuroVirology. 4(5). 474–485. 46 indexed citations
15.
Galasso, George J., Richard J. Whitley, & Thomas C. Merigan. (1997). Antiviral agents and human viral diseases.. 36 indexed citations
16.
Kimberlin, David W., Dwight A. Powell, William C. Gruber, et al.. (1996). Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a Phase I/II trial. The Pediatric Infectious Disease Journal. 15(3). 247–254. 91 indexed citations
17.
Zhou, Xiaojian, William C. Gruber, Gail J. Demmler, et al.. (1996). Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections.. Clinical Pharmacology & Therapeutics. 59(2). 184–184. 9 indexed citations
18.
Lakeman, Fred D. & Richard J. Whitley. (1995). Diagnosis of Herpes Simplex Encephalitis: Application of Polymerase Chain Reaction to Cerebrospinal Fluid from Brain-Biopsied Patients and Correlation with Disease. The Journal of Infectious Diseases. 171(4). 857–863. 446 indexed citations breakdown →
19.
Gruber, William C., Gregory A. Storch, Gail J. Demmler, et al.. (1993). Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Clinical Pharmacology & Therapeutics. 53(1). 15–21. 70 indexed citations
20.
McCracken, George H., Merle A. Sande, Arnold Lentnek, Richard J. Whitley, & W. Michael Scheid. (1992). Evaluation of New Anti-Infective Drugs for the Treatment of Acute Bacterial Meningitis. Clinical Infectious Diseases. 15(Supplement_1). S182–S188. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley A. Plotkin Breakdown of academic impact, for papers by Herbert W. Virgin Breakdown of academic impact, for papers by Ann M. Arvin Breakdown of academic impact, for papers by Lawrence Corey Breakdown of academic impact, for papers by Barry R. Bloom Breakdown of academic impact, for papers by Anna Wald Breakdown of academic impact, for papers by André J. Nahmias Breakdown of academic impact, for papers by Akiko Iwasaki Breakdown of academic impact, for papers by Michael B. A. Oldstone Breakdown of academic impact, for papers by Ron A. M. Fouchier
Rankless by CCL
2026